New pill aims to shield stomachs from common painkiller damage
NCT ID NCT07533266
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new medicine called Fexuprazan (Fexuclue) can prevent stomach ulcers caused by NSAID painkillers like ibuprofen. About 360 adults with joint or muscle pain who need daily NSAIDs will take either Fexuprazan or an older drug (Lansoprazole) for 24 weeks. The goal is to see if Fexuprazan works as well at preventing ulcers and is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fexuprazan (Fexuclue)
What this could lead to
If it works, this could offer a new option to prevent painful stomach ulcers in people who need long-term NSAIDs for arthritis or similar conditions.
What could go wrong
This is a Phase 4 trial comparing Fexuprazan to an existing drug (Lansoprazole), so it may only show it works as well, not better. The study hasn't started yet, and results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••